ArticlePloS one2022
Predictors and outcomes of peritoneal dialysis-related infections due to filamentous molds (MycoPDICS).
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 21 citations in OpenAlex.
- When "Medical mycology case reports · 2026Article
- Changing Pattern of Peritoneal Dialysis-Related Fungal Peritonitis: A 21-Year Single-Center Experience.Kidney medicine · 2026Article
- Skull base invasive aspergillosis in a peritoneal dialysis patient: A rare and devastating complication.Medical mycology case reports · 2026Article
- From black particles to molecular proof: PD-associated peritonitis byMedical mycology case reports · 2026Article
- Article
- Article
- First human case ofMedical mycology case reports · 2025Article
- Timely diagnosis and management ofMedical mycology case reports · 2025Article
- Black mold in the bag room: First case ofIDCases · 2025Article
- Peritoneal dialysis-related peritonitis caused byFrontiers in fungal biology · 2025Article
- A Silent Threat Unveiled: Mycobacterium gordonae Catheter-Related Peritonitis in a Patient on Peritoneal Dialysis.Cureus · 2024Article
- Peritoneal dialysis-associated peritonitis due to infected umbilicus.Medical mycology case reports · 2024Article
- Caregiver skin infection causing peritoneal dialysis-associated peritonitis.Medical mycology case reports · 2024Article
- Article
- Serum Galactomannan: A Predictor of Poor Outcomes in Peritoneal Dialysis Patients With Fungal Peritonitis.Kidney international reports · 2024Article
- Peritoneal dialysis-associated peritonitis from pauci-septated mold: Life-threatening but curable.Medical mycology case reports · 2023Article
- Peritonitis due toMedical mycology case reports · 2023Article
- Fungal Peritonitis in Peritoneal Dialysis: An 18-year Experience from Nizwa Hospital, Sultanate of Oman.Saudi journal of medicine & medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 18 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWe sought to evaluate the predictors and outcomes of mold peritonitis in patients with peritoneal dialysis (PD).
methodsThis cohort study included PD patients from the MycoPDICS database who had fungal peritonitis between July 2015-June 2020. Patient outcomes were analyzed by Kaplan Meier curves and the Log-rank test. Multivariable Cox proportional hazards model regression was used to estimating associations between fungal types and patients' outcomes.
resultsThe study included 304 fungal peritonitis episodes (yeasts n = 129, hyaline molds n = 122, non-hyaline molds n = 44, and mixed fungi n = 9) in 303 patients. Fungal infections were common during the wet season (p <0.001). Mold peritonitis was significantly more frequent in patients with higher hemoglobin levels, presentations with catheter problems, and positive galactomannan (a fungal cell wall component) tests. Patient survival rates were lowest for non-hyaline mold peritonitis. A higher hazard of death was significantly associated with leaving the catheter in-situ (adjusted hazard ratio [HR] = 6.15, 95%confidence interval [CI]: 2.86-13.23) or delaying catheter removal after the diagnosis of fungal peritonitis (HR = 1.56, 95%CI: 1.00-2.44), as well as not receiving antifungal treatment (HR = 2.23, 95%CI: 1.25-4.01) or receiving it for less than 2 weeks (HR = 2.13, 95%CI: 1.33-3.43). Each additional day of antifungal therapy beyond the minimum 14-day duration was associated with a 2% lower risk of death (HR = 0.98, 95%CI: 0.95-0.999).
conclusionNon-hyaline-mold peritonitis had worse survival. Longer duration and higher daily dosage of antifungal treatment were associated with better survival. Deviations from the 2016 ISPD Peritonitis Guideline recommendations concerning treatment duration and catheter removal timing were independently associated with higher mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.